Neoantigen Prediction for Precision Immunotherapies 

 LIVE Symposium

Friday, February 24, 2022
11:00 AM – 2:00 PM Eastern Time

Researchers develop immunotherapies based on cancer mutations that produce neoantigens. These proteins are unique to tumors and facilitate immune system activation. Researchers predict neoantigens using sequencing methodologies and develop modified immune cells including T cells, NK cells, and dendritic cells. 

In this symposium brought to you by The Scientist’s Creative Services Team, researchers will highlight tools and resources used to hunt for neoantigens and discuss how neoantigen T cell receptors (TCRs) are proving effective in destroying tumors.

Symposium program

11:00 AM – Introduction

11:10 AM – TBD

Paul Thomas, PhD

11:45 AM – Drugging intracellular targets with antibodies

David Scheinberg, MD, PhD

12:20 PM – TBD

12:55 PM – TBD

1:30 PM – Open panel Q&A session
Deanna MacNeil from The Scientist’s Creative Services Team will be joined by the entire panel in an open question and answer session where presenters will address questions posed by the audience.

David Scheinberg, MD, PhD Chairman, Center for Experimental Therapeutics Deputy Director for Therapeutic Discovery Sloan Kettering Institute Memorial Sloan Kettering Cancer Center